BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 26569152)

  • 1. Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS.
    Morrow SA; Rosehart H; Pantazopoulos K
    J Neuropsychiatry Clin Neurosci; 2016; 28(2):118-23. PubMed ID: 26569152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
    Hegedüs K; Kárpáti J; Iljicsov A; Simó M
    Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between depression and cognitive decline in sclerosis multiplex patients].
    Hegedüs K; Kárpáti J; Szombathelyi É; Simó M
    Neuropsychopharmacol Hung; 2015 Mar; 17(1):31-6. PubMed ID: 25935381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
    Wuerfel E; Weddige A; Hagmayer Y; Jacob R; Wedekind L; Stark W; Gärtner J
    PLoS One; 2018; 13(3):e0194873. PubMed ID: 29566099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
    Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported cognitive function mediates the relationship between employment status and cognitive functioning in persons with multiple sclerosis.
    Espiritu AI; Soliman Y; Blair M; Santo J; Casserly C; Racosta JM; Morrow SA
    Mult Scler Relat Disord; 2024 Jul; 87():105645. PubMed ID: 38761696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints.
    Wallis O; Bol Y; Köhler S; van Heugten C
    Acta Neurol Scand; 2020 Mar; 141(3):212-218. PubMed ID: 31693750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: The role of information processing speed impairment.
    Labiano-Fontcuberta A; Mitchell AJ; Moreno-García S; Benito-León J
    J Neurol Sci; 2015 Feb; 349(1-2):220-5. PubMed ID: 25638658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and psychiatric comorbidities in neuromyelitis optica.
    Moore P; Methley A; Pollard C; Mutch K; Hamid S; Elsone L; Jacob A
    J Neurol Sci; 2016 Jan; 360():4-9. PubMed ID: 26723962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.
    Blair M; Gill S; Gutmanis I; Smolewska K; Warriner E; Morrow SA
    J Clin Exp Neuropsychol; 2016 Sep; 38(7):782-94. PubMed ID: 27144616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep and its associations with perceived and objective cognitive impairment in individuals with multiple sclerosis.
    Hughes AJ; Parmenter BA; Haselkorn JK; Lovera JF; Bourdette D; Boudreau E; Cameron MH; Turner AP
    J Sleep Res; 2017 Aug; 26(4):428-435. PubMed ID: 28093823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capacity for financial decision making in multiple sclerosis.
    Tracy VL; Basso MR; Marson DC; Combs DR; Whiteside DM
    J Clin Exp Neuropsychol; 2017 Feb; 39(1):46-57. PubMed ID: 27430343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognition in early relapsing-remitting multiple sclerosis: consequences may be relative to working memory.
    Berrigan LI; Lefevre JA; Rees LM; Berard J; Freedman MS; Walker LA
    J Int Neuropsychol Soc; 2013 Sep; 19(8):938-49. PubMed ID: 23866100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social cognition according to cognitive impairment in different clinical phenotypes of multiple sclerosis.
    Dulau C; Deloire M; Diaz H; Saubusse A; Charre-Morin J; Prouteau A; Brochet B
    J Neurol; 2017 Apr; 264(4):740-748. PubMed ID: 28220288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep and Cognitive Function in Multiple Sclerosis.
    Braley TJ; Kratz AL; Kaplish N; Chervin RD
    Sleep; 2016 Aug; 39(8):1525-33. PubMed ID: 27166237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing patient and informant ratings of depressive symptoms in various stages of Alzheimer's disease.
    Gold D; Rosowsky E; Piryatinsky I; Sinclair SJ
    Neuropsychology; 2020 Jul; 34(5):535-550. PubMed ID: 32191055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifocal cognitive dysfunction in high-dose benzodiazepine users: a cross-sectional study.
    Federico A; Tamburin S; Maier A; Faccini M; Casari R; Morbioli L; Lugoboni F
    Neurol Sci; 2017 Jan; 38(1):137-142. PubMed ID: 27730361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.